PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
PROTHENA CORP PUBLIC LTD CO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$8.48+0.13 (+1.56%)
Close on Oct 19, 2026
- Market cap
- $442.19M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Prothena Corp Public has not reported a dividend
No dividend per share appears in Prothena Corp Public's annual filings since fiscal 2010.